GZGuang Zeng

Guang Zeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guang Zeng has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Beiping Hu

    Department of Epidemiology, Center for Global Health, School of Public Health Nanjing Medical University Nanjing China

    1 shared publication
  • Guangfu Jin

    State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Guanlin Li

    Department of Oncology, Shanghai Medical College Fudan University Shanghai China

    1 shared publication
  • Guoqiang Lu

    Department of Epidemiology, School of Public Health, and The Research Institute for Cancer Control and Prevention, Greater Bay Area Institute of Precision Medicine (Guangzhou) Fudan University Shanghai China

    1 shared publication
  • Hongliang Liu

    Department of Epidemiology, School of Public Health, and The Research Institute for Cancer Control and Prevention, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, China

    1 shared publication
  • Lei Cheng

    Department of Pulmonary, Shanghai Chest Hospital Shanghai Jiao Tong University Shanghai China

    1 shared publication

Latest Publications

  • Potentially Functional Variants in FCER1A and PLCG2 , Two B Cell‐Related Immune Genes Predict the Survival of Chinese Gastric Cancer Patients

    by Guang Zeng, Guoqiang Lu, Beiping Hu, Midie Xu, Guanlin Li, Mengyun Wang, Lixin Qiu, Lei Cheng, Ruoxin Zhang, Wanghong Xu, et al.

    B cells are integral components of the tumor microenvironment (TME) and influence the progression, prognosis, and immunotherapy response of gastric cancer (GC). However, the prognostic relevance of germline variants in B cell‐related immune genes remains undefined. We performed a two‐stage genome‐wide association analysis to identify single‐nucleotide polymorphisms (SNPs) in B cell‐related immune genes associated with overall survival (OS) in patients with pathologic tumor‐node‐metastasis (pTNM) stage I–III GC. Clinical, follow‐up, and genome‐wide association study (GWAS) genotyping data were analyzed from two independent Eastern Chinese cohorts (Shanghai, N = 2211; Jiangsu, N = 1049). Functional annotation, quantitative trait loci (QTL), and immune infiltration analyses were conducted. Among 15,857 SNPs across 223 genes, 210 were associated with OS in the discovery cohort, nine of which were validated. Two independent functional variants— FCER1A rs539959920 C > T and PLCG2 rs72832034 C > T—were consistently associated with poorer OS (adjusted HR = 1.19, 95% CI = 1.04–1.37, p = 0.014; HR = 1.34, 95% CI = 1.09–1.64, p = 0.005). Patients carrying multiple unfavorable genotypes exhibited a dose‐dependent decline in survival ( P trend = 0.002). Incorporation of these SNPs modestly improved time‐dependent AUCs for OS prediction at 36 months. Single‐cell expression and splicing QTL analyses demonstrated allele‐specific modulation of FCER1A and PLCG2 expression across immune cell subsets, consistent with altered immune infiltration patterns in the GC TME. These findings suggest that two germline variants in FCER1A and PLCG2 independently predict GC survival, likely through transcriptional and immunologic modulation, thereby nominating these variants as potential immune‐genetic biomarkers for GC prognosis and therapeutic stratification.